We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
Cap. Flow
-$438M
Cap. Flow %
-78.37%
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$10.5M
2
C icon
Citigroup
C
+$10.5M
3
MSFT icon
Microsoft
MSFT
+$9.87M
4
OPTU
Optimum Communications Inc
OPTU
+$9.41M
5
AES icon
AES
AES
+$7.92M

Sector Composition

Rank Sector Weight
1 Technology 25.93%
2 Consumer Discretionary 17.95%
3 Healthcare 12.14%
4 Communication Services 8.7%
5 Financials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTZ icon
601
MasTec
MTZ
$21.4B
-8,702
Closed -$751K
MU icon
602
Micron Technology
MU
$1.01T
-39,920
Closed -$2.83M
NBIX icon
603
Neurocrine Biosciences
NBIX
$16.4B
-3,616
Closed -$347K
NEM icon
604
Newmont
NEM
$110B
-20,322
Closed -$1.1M
NRG icon
605
NRG Energy
NRG
$25.5B
-9,653
Closed -$394K
NSC icon
606
Norfolk Southern
NSC
$76.8B
-17,670
Closed -$4.23M
NTAP icon
607
NetApp
NTAP
$36.6B
-39,312
Closed -$3.53M
NTNX icon
608
Nutanix
NTNX
$16.5B
-107,739
Closed -$4.06M
NTRA icon
609
Natera
NTRA
$39.3B
-6,206
Closed -$692K
NVDA icon
610
NVIDIA
NVDA
$5.31T
-124,410
Closed -$2.58M
NVO
611
Novo Nordisk
NVO
$197B
-6,758
Closed -$324K
NVS icon
612
Novartis
NVS
$294B
-11,701
Closed -$957K
NVT icon
613
nVent Electric
NVT
$26.2B
-7,600
Closed -$246K
NWL icon
614
Newell Brands
NWL
$2.63B
-55,407
Closed -$1.23M
NYT icon
615
New York Times
NYT
$10.6B
-8,471
Closed -$417K
OKTA icon
616
Okta
OKTA
$25.6B
-2,396
Closed -$569K
ONTF
617
DELISTED
ON24
ONTF
-12,200
Closed -$243K
ORI icon
618
Old Republic International
ORI
$10.5B
-20,494
Closed -$474K
OVV icon
619
Ovintiv
OVV
$16B
-10,791
Closed -$355K
PCAR icon
620
PACCAR
PCAR
$70.2B
-81,030
Closed -$4.26M
PD icon
621
PagerDuty
PD
$865M
-54,020
Closed -$2.24M
PDD icon
622
Pinduoduo
PDD
$129B
-27,191
Closed -$2.46M
PFG icon
623
Principal Financial Group
PFG
$24.6B
-18,310
Closed -$1.18M
PFGC icon
624
Performance Food Group
PFGC
$17.6B
-10,026
Closed -$466K
PGR icon
625
Progressive
PGR
$124B
-56,615
Closed -$5.12M

Similar funds

Seven Eight Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.

  • Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
  • Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
  • Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
  • Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
  • Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
  • Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
  • Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.

Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.